Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

REMS Reform Seems Distant Goal For Generics After Limited Support At US House Hearing

Mar 03 2017

• By Michael Cipriano

Related Content

REMS And Generics: GPhA Needs Legislation, Continues Education

Aug 04 2014

Bill To Speed ANDA Approvals Gets Cool Reception From Industry, US FDA

Mar 03 2017

Shkreli Fallout Continues: PhRMA Seems To Soften Stance On REMS Legislation

Jun 22 2016

REMS Abuse Legislation: GPhA and PhRMA Set To Battle Again

Jun 16 2016

Related Companies

Momenta Pharmaceuticals, Inc.

Vyera Pharmaceuticals, LLC

Additional Topics

United States Generic Drugs Risk Management Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window